Use of mva to treat prostate cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01)

Patent

CA 2702586

The invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses can induce B- and T-cell responses. The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane.

L'invention porte sur des compositions, des coffrets et des procédés pour une prophylaxie et une thérapie du cancer à l'aide de virus MVA recombinants codant pour des antigènes associés à la tumeur, tels que PSA et PAP. Les virus MVA recombinants peuvent induire des réponses des lymphocytes B et T. Les virus MVA recombinants peuvent être administrés avant, pendant ou après une taxane.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of mva to treat prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of mva to treat prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mva to treat prostate cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1453205

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.